Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications12

MLA

Imperiale, Alessio, et al. “Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications12.” Neoplasia (New York, N.Y.), vol. 17, no. 1, Jan. 2015, pp. 55–65. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........27cfa5acc964ec0fccacea9a0f4b73ad&authtype=sso&custid=ns315887.

APA

Imperiale, A., Moussallieh, F.-M., Roche, P., Battini, S., Cicek, A. E., Sebag, F., Brunaud, L., Barlier, A., Elbayed, K., Loundou, A., Bachellier, P., Goichot, B., Stratakis, C. A., Pacak, K., Namer, I.-J., & Taïeb, D. (2015). Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications12. Neoplasia (New York, N.Y.), 17(1), 55–65.

Chicago

Imperiale, Alessio, François-Marie Moussallieh, Philippe Roche, Stéphanie Battini, A. Ercument Cicek, Frédéric Sebag, Laurent Brunaud, et al. 2015. “Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications12.” Neoplasia (New York, N.Y.) 17 (1): 55–65. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........27cfa5acc964ec0fccacea9a0f4b73ad&authtype=sso&custid=ns315887.